The book addresses the challenges in drug therapy for both humans and animals, focusing on the limitations of current biologically active substances (BAS). It highlights the insufficient effectiveness and significant side effects of existing medications, particularly antimicrobials like antibiotics, which face issues of reduced efficacy due to microbial resistance. Additionally, it discusses the impact of drug use on the quality of animal products and the associated risks to human health, emphasizing the urgent need for new therapeutic solutions.
